About Precision Medicine Advisors
Who We Are
We are experts in clinical applications of genomics who believe that for precision medicine to take hold, all players in the precision medicine ecosystem would benefit from increased awareness, a base of genomic literacy and skills to implement genetic testing.
PMA specializes in communicating precision medicine to lay professional audiences, providing scientifically sound, unbiased information to promote the responsible use of genomics in medicine.
Featured in The Precision Medicine Podcast: Episode 7
Jeanette McCarthy, MPH, PhD is a UC Berkeley trained genetic epidemiologist and spent the early part of her career in industry at Millennium Pharmaceuticals before transitioning to academia. She currently holds adjunct faculty positions at UCSF and Duke University. Her previous research had focused on the genetic underpinnings of complex diseases, both infectious and chronic. More recently, she has become a leading educator in the field of genomic and precision medicine. Jeanette helped launch the first consumer-facing magazine in this field, Genome, and served as Editor-in-Chief from 2014-2016. She developed the first MOOC on precision medicine, offered through Coursera, and teaches at UCSF and UC Berkeley Extension as well. Jeanette is coauthor of the book, Precision Medicine: A Guide to Genomics in Clinical Practice (from McGraw Hill Education).
Connect with Jeanette on LinkedIn.
Vice President of Business Development
Shervin Kamkar is a business development and market strategy leader with over 15 years' experience in the genomics, life sciences, and diagnostics space. Most recently he was at Illumina, the market leader in next generation sequencing, where he was Commercial Business Head for the Understand Your Genome® (UYG) symposia - Illumina’s innovative, clinically responsible, experiential education program.
Shervin has a B.S. in Microbiology from the University of California, Santa Barbara and a MS in Molecular Biology from San Francisco State University and the University of California, San Francisco, where his research and thesis were focused on the identification and characterization of tumor suppressor genes in prostate cancer.
Connect with Shervin on LinkedIn.